Your browser doesn't support javascript.
loading
Development, verification, and comparison of a risk stratification model integrating residual cancer burden to predict individual prognosis in early-stage breast cancer treated with neoadjuvant therapy.
Hou, N; Wu, J; Xiao, J; Wang, Z; Song, Z; Ke, Z; Wang, R; Wei, M; Xu, M; Wei, J; Qian, X; Xu, X; Yi, J; Wang, T; Zhang, J; Li, N; Fan, J; Hou, G; Wang, Y; Wang, Z; Ling, R.
Affiliation
  • Hou N; Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China.
  • Wu J; Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China.
  • Xiao J; Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China.
  • Wang Z; Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China.
  • Song Z; Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China.
  • Ke Z; Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China.
  • Wang R; Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China.
  • Wei M; Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China.
  • Xu M; Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China.
  • Wei J; Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China.
  • Qian X; Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China.
  • Xu X; Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China.
  • Yi J; Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China.
  • Wang T; Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China.
  • Zhang J; Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China.
  • Li N; Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China.
  • Fan J; Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China.
  • Hou G; Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China.
  • Wang Y; Department of Geriatrics, Union Hospital of Tongji Medical College, Huazhong University of Science & Technology, Wuhan, PR China.
  • Wang Z; Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China. Electronic address: zhwang@fmmu.edu.cn.
  • Ling R; Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China. Electronic address: lingrui0105@163.com.
ESMO Open ; 6(5): 100269, 2021 10.
Article in En | MEDLINE | ID: mdl-34537675
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoadjuvant Therapy / Triple Negative Breast Neoplasms Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: ESMO Open Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoadjuvant Therapy / Triple Negative Breast Neoplasms Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: ESMO Open Year: 2021 Type: Article